Sound Income Strategies LLC Acquires 15,638 Shares of National Health Investors, Inc. $NHI
Sound Income Strategies LLC increased its stake in National Health Investors, Inc. (NYSE:NHI) by 6.5% in the fourth quarter, acquiring an additional 15,638 shares to bring its total holdings to 256,898 shares, valued at approximately $20.6 million. The company recently declared a quarterly dividend of $0.92 per share, and analysts currently rate NHI as a "Moderate Buy" with an average price target of $86.83. National Health Investors, a real estate investment trust, focuses on owning and financing healthcare and senior housing facilities in the United States.
National Health Investors invests $74.3M to add 344 units in Oklahoma and Oregon to portfolio
National Health Investors has invested $74.3 million to acquire 344 units across two senior living communities in Oklahoma and Oregon. This acquisition expands their portfolio and includes a 140-unit continuing care retirement community in Oklahoma City and a 204-unit independent living community in Tigard, Oregon. The investment highlights NHI's strategy to grow its presence in the senior housing market in diverse geographical locations.
NATIONAL HEALTH INVESTORS INC ($NHI) CEO 2025 Pay Revealed
The CEO of National Health Investors Inc. ($NHI), D. Eric Mendelsohn, is estimated to have received $3,652,795 in compensation in 2025, a 38.5% increase from 2024, based on a recent DEF14A SEC filing. The article also details congressional stock trading activity for NHI, showing one purchase by Representative Gilbert Ray Cisneros, Jr., and institutional investor movements, with major shifts by funds like Macquarie Group Ltd. and JPMorgan Chase & Co. Additionally, it highlights analyst ratings and price targets for $NHI, with a median target of $88.0 from three analysts.
National Health Investors invests $74.3M to add 344 units in Oklahoma and Oregon to portfolio
National Health Investors (NHI) announced a $74.3 million investment to acquire two senior living communities, totaling 344 units, in Oklahoma and Oregon. This acquisition increases NHI's senior housing portfolio and demonstrates its continued focus on expanding its presence in key markets. The investment is expected to contribute to the company's growth strategy.
NHI PE Ratio & Valuation, Is NHI Overvalued
National Health Investors Inc (NHI) is currently considered undervalued based on its forward PE ratio of 18.15 compared to its five-year average of 20.87. Its fair price is estimated to be between $85.79 and $108.55, making the current price of $83.16 undervalued by 3.07%. While NHI's P/S ratio is above the industry average, this is deemed sustainable due to robust revenue growth.
Net current asset value per share of National Health Investors, Inc. – DUS:WX6
This page from TradingView provides a financial overview for National Health Investors, Inc. (DUS:WX6) on the Dusseldorf Stock Exchange. It specifically highlights the net current asset value per share for the company, though the actual value is not displayed in the provided content. The page also includes navigation for various market data, community features, and product offerings from TradingView.
National Health Investors, Inc. (NYSE:NHI) Short Interest Up 19.1% in March
National Health Investors, Inc. (NYSE:NHI) saw a 19.1% increase in short interest during March, reaching 1,479,704 shares, which represents 3.3% of its float and a days-to-cover ratio of 4.7. The company announced a quarterly dividend of $0.92 per share, equating to an annualized $3.68 and a 4.6% yield, with an ex-dividend date of March 31st and a payout ratio of 121.85%. Despite missing Q4 EPS estimates by $0.01, NHI's revenue beat expectations, and the company set a positive FY2026 EPS guidance above analyst forecasts.
HPP vs. NHI: Which Stock Is the Better Value Option?
This article compares Hudson Pacific Properties (HPP) and National Health Investors (NHI) to determine which is the better value stock. Based on the Zacks Rank, Style Scores, and various valuation metrics like P/E, PEG, and P/B ratios, HPP is identified as the superior option for value investors currently.
How (NHI) Movements Inform Risk Allocation Models
This article analyzes National Health Investors Inc. (NYSE: NHI) using AI models to provide trading strategies and risk allocation insights. It identifies a mid-channel oscillation pattern and highlights divergent sentiment across various time horizons, suggesting choppy market conditions. The analysis details a short setup with a favorable risk-reward ratio, along with specific long, breakout, and short strategies tailored to different risk profiles.
Omitted stock option grant corrected for NHI (NYSE: NHI) SVP
National Health Investors (NYSE: NHI) has updated an insider ownership report for SVP, Legal Affairs Elizabeth Jackson Blankenship, correcting a previously omitted stock option grant. The amendment details three tranches of stock options, each with an exercise price of $73.34 per share and an expiration date of March 3, 2030, covering a total of 25,000 shares of common stock. The options become exercisable in stages on March 3, 2025, 2026, and 2027, clarifying her direct right to acquire NHI Common Stock.
How Investors Are Reacting To National Health Investors (NHI) Expanding Its At-the-Market Equity Program
National Health Investors (NHI) has expanded its at-the-market equity program with a US$500 million offering and an omnibus shelf registration, increasing its funding flexibility. This move, alongside the affirmation of its dividend, emphasizes NHI's strategy to fund senior housing investments while managing dilution and maintaining per-share metrics. Investors are cautioned about the potential impact of continued equity issuance on per-share FFO and earnings, while fair value estimates for NHI vary widely.
NHI (NYSE: NHI) CFO Spaid granted 5,072 shares after award correction
National Health Investors Inc. (NHI) CFO John L. Spaid was granted 5,072 shares of common stock on March 3, 2026, as a compensation award. This corrects a previous administrative error where the award was understated by 346 shares, bringing his total direct ownership to 56,600.637 shares. The transaction, classified as a grant/award at $0.00 per share, was reported via an amended Form 4/A filing.
[Form 4/A] NATIONAL HEALTH INVESTORS INC Amended Insider Trading Activity
This article details an amended Form 4/A filing by National Health Investors Inc. (NHI) correcting an administrative error regarding an insider transaction. Kevin Carlton Pascoe, Chief Investment Officer, received a grant of 4,726 shares of common stock on March 3, 2026, at no cost, which increased his direct holdings to 73,082 shares. The amendment clarifies that the original report overstated the award by 346 shares.
National Health Investors Inc To Go Ex-Dividend On March 31st, 2026 With 0.92 USD Dividend Per Share
National Health Investors Inc will go ex-dividend on March 31st, 2026. The company is expected to distribute a dividend of 0.92 USD per share to its shareholders. This announcement is relevant for investors tracking dividend income.
How Investors Are Reacting To National Health Investors (NHI) Expanding Its At-the-Market Equity Program
National Health Investors (NHI) recently expanded its at-the-market equity program with a US$500 million offering, alongside an omnibus shelf registration. This move increases the REIT's funding flexibility for senior housing investments but raises concerns about potential dilution to per-share metrics. Investors are urged to consider multiple perspectives on NHI's long-term performance given the varying fair value estimates and dilution risks.
EBIT per share of National Health Investors, Inc. – SWB:WX6
The article displays the "EBIT per share" for National Health Investors, Inc. (SWB:WX6) on the TradingView platform. It presents financial data including historical period values and their changes, sourced from ICE Data Services and FactSet. The content is primarily a data display page with common website navigation and disclaimers.
Cash per share of National Health Investors, Inc. – SWB:WX6
This article provides financial data for National Health Investors, Inc. (SWB:WX6) on the Stuttgart Stock Exchange, specifically focusing on its cash per share. It presents a table showing the period, value, change, and percentage change for this metric.
Vanguard disaggregates holdings; reports 0 shares in National Health Investors (NHI)
The Vanguard Group has filed a Schedule 13G/A amendment for National Health Investors (NHI), reporting zero beneficial ownership of the company's common stock. This change is due to an internal realignment on January 12, 2026, which led certain Vanguard subsidiaries to disaggregate their holdings and report them separately in accordance with SEC Release No. 34-39538. Vanguard explicitly states it no longer has beneficial ownership over securities held by these subsidiaries.
National Health Investors (NYSE:NHI) Price Target Raised to $86.00
Wells Fargo raised its price target for National Health Investors (NHI) shares to $86.00 from $85.00, maintaining an "equal weight" rating, while the company's consensus target is $86.83 with a "Moderate Buy" average rating. NHI's recent quarterly results showed a revenue beat and strong FY 2026 EPS guidance that surpassed street estimates. Institutional investors, including Vanguard and JPMorgan, are increasing their stakes in the real estate investment trust.
National Health Investors Stock: Steady REIT Play in Senior Housing and Healthcare Real Estate Marke
National Health Investors (NHI) is a real estate investment trust focused on senior housing and skilled nursing facilities in the U.S. The company acquires, owns, and finances healthcare properties, generating stable rental income through long-term agreements with operators. NHI benefits from the aging population demographic and offers investors diversification with inflation-hedging properties and competitive yields.
National Health Investors Stock: Steady REIT Play in Senior Housing and Healthcare Real Estate Marke
National Health Investors (NHI) is a real estate investment trust (REIT) specializing in senior housing and skilled nursing facilities, offering North American investors exposure to healthcare real estate. The company's business model involves acquiring, owning, and financing properties leased to operators, generating stable rental income. NHI's growth is driven by demographic shifts, strategic acquisitions, and a focus on high-quality assets, making it an attractive option for income-focused investors despite risks like interest rate sensitivity and regulatory changes.
EBITDA per share of National Health Investors, Inc. – SWB:WX6
This article provides financial information for National Health Investors, Inc. (SWB:WX6), specifically focusing on its EBITDA per share. It appears to be a stub or data-driven page from TradingView, indicating market performance data and financial metrics. The primary content is the title itself, with the body discussing the availability of period values, changes, and change percentages related to EBITDA per share.
Trading Systems Reacting to (NHI) Volatility
This article from Stock Traders Daily discusses how trading systems are reacting to volatility in National Health Investors Inc. (NHI). It provides key findings, including neutral near and mid-term readings that could moderate a long-term positive bias, and highlights an exceptional short setup. The content details institutional trading strategies generated by AI models tailored to different risk profiles.
National Health Investors Expands Capital Options With Equity Raise And Shelf Filing
National Health Investors (NYSE:NHI) has announced a $500 million follow-on equity offering and a new shelf registration to broaden its funding options. This move provides the healthcare-focused REIT with flexible access to capital for future property investments, tenant support, and balance sheet management. Investors are advised to monitor how quickly NHI utilizes these new capital avenues and the allocation of proceeds between growth projects and financial objectives.
National Health Investors Expands Capital Options With Equity Raise And Shelf Filing
National Health Investors (NYSE:NHI) has launched a $500 million follow-on equity offering and filed a new shelf registration to provide flexible access to capital for future corporate needs. These actions aim to broaden the healthcare REIT's funding options for property investments, tenant support, or balance sheet priorities. Investors should monitor how NHI utilizes these capital tools and how proceeds are allocated to growth projects or financial objectives.
NHI outlines 70% of 2026 investments for SHOP platform amid record $392M annual acquisitions
NHI plans to allocate 70% of its 2026 investments to its SHOP platform, focusing on senior housing operating portfolios. This strategic shift follows a record-breaking $392 million in annual acquisitions for 2025, primarily targeting independent living, assisted living, and memory care facilities. The move aims to enhance growth through strategic capital deployment within these core segments.
National Health Investors invests $74.3M to add 344 units in Oklahoma and Oregon to portfolio
National Health Investors (NHI) has announced a $74.3 million investment to acquire two senior living communities, totaling 344 units, in Oklahoma and Oregon. These acquisitions will be leased to affiliates of The Graceland Group and are expected to generate an initial cash yield of 7.25%, with annual escalators of 2.25%. The deal includes a five-year master lease for both properties.
National Health Investors Launches $500 Million Equity Offering Program
National Health Investors (NHI) has initiated an Equity Distribution Agreement to offer up to $500 million of its common stock. The proceeds will be used for general corporate purposes, including potential acquisitions and debt repayment. An analyst has a Buy rating on NHI stock with a $92.00 price target, and TipRanks' AI Analyst, Spark, rates NHI as Outperform, citing constructive technical momentum and a solid REIT cash-flow profile, despite some valuation and reliability concerns.
Militia Capital Partners LP Purchases New Holdings in National Health Investors, Inc. $NHI
Militia Capital Partners LP has acquired a new position in National Health Investors (NHI) by purchasing 13,100 shares valued at approximately $1.04 million. Institutional investors now hold 62.51% of the company's stock. NHI recently missed EPS estimates but beat revenue expectations, and has declared a quarterly dividend of $0.92, offering a 4.3% yield despite a high payout ratio.
National Health Investors (NYSE: NHI) launches $500M ATM, forward sale plan
National Health Investors (NHI) has launched an At-The-Market (ATM) equity distribution program and forward sale plan for up to $500 million of common stock. This initiative allows the company to sell shares through various financial institutions, either directly as sales agents or via forward sale agreements. The net proceeds from these offerings are intended for general corporate purposes, including potential future acquisitions and repayment of indebtedness.
National Health Investors Launches $500 Million Equity Offering Program
National Health Investors (NHI) has launched a $500 million at-the-market equity offering program, allowing the company to sell common stock through various methods, including direct sales and forward sale agreements. The proceeds are intended for general corporate purposes, potential acquisitions, and debt reduction. An analyst currently rates NHI stock as a Buy with a $92.00 price target, and TipRanks' AI Analyst also gives it an "Outperform" signal.
NHI (NYSE: NHI) registers $500M at-the-market equity program with forward-sale option
National Health Investors, Inc. (NYSE: NHI) has registered a $500 million at-the-market (ATM) equity distribution program, which includes a forward-sale option. The program allows NHI to offer and sell common stock through various broker-dealers at prevailing market prices. This move aims to provide capital for general corporate purposes, including future acquisitions and debt repayment, while offering flexibility in settlement options.
Will Strong Q4 Beat And Acquisition Capacity Shift National Health Investors' (NHI) Narrative
National Health Investors (NHI) recently reported Q4 2025 results that surpassed analyst expectations, with strong revenue figures. The company's solid financial position, as noted by analysts, suggests it can support future acquisition activities without stressing its balance sheet. This performance and acquisition capacity may influence NHI's investment narrative, particularly concerning its ability to grow in the senior housing market, although execution risks remain.
Will Strong Q4 Beat And Acquisition Capacity Shift National Health Investors' (NHI) Narrative
National Health Investors (NHI) reported a strong Q4 2025 performance, exceeding revenue expectations, which highlights its capacity for future acquisitions without stressing its balance sheet. This positive financial standing and acquisition potential are key to its investment narrative, though risks related to execution and senior housing occupancy remain. The company's affirmed dividend commitment signals confidence in its cash generation and capital allocation strategies.
National Health Investors (NYSE:NHI) Given New $92.00 Price Target at Truist Financial
Truist Financial has increased its price target for National Health Investors (NYSE:NHI) to $92.00 from $85.00, maintaining a "buy" rating for the real estate investment trust. This new target suggests a potential upside of 6.46% from the company's previous closing price. The company recently reported Q4 EPS of $1.22, slightly missing estimates, but exceeded revenue expectations with $105.82 million, and provided FY2026 EPS guidance between $4.94 and $4.99.
Truist Financial Maintains National Health Investors Inc(NHI.US) With Buy Rating, Announces Target Price $92
Truist Financial has maintained a Buy rating on National Health Investors Inc (NHI.US) and set a target price of $92. Analyst Michael Lewis, who has a 59.4% success rate and an 8.2% average return according to TipRanks, issued the rating. This information is intended for informational purposes only and not as investment advice.
Truist raises National Health Investors price target on growth outlook By Investing.com
Truist Securities has increased its price target for National Health Investors (NYSE:NHI) to $92 from $85, maintaining a Buy rating. The adjustment reflects optimism about the company's senior housing operating portfolio and its ability to pursue acquisitions, despite recent underperformance in late 2025. National Health Investors also reported strong Q4 2025 earnings, surpassing revenue and EPS expectations.
A Look At National Health Investors (NHI) Valuation After Mixed 2025 Earnings Results
National Health Investors (NHI) recently reported mixed Q4 and full-year 2025 results, with higher sales and revenue but softer quarterly earnings, indicating margin pressures. Despite a share price near the analyst target and a positive one-year return of 19.8%, the narrative suggests NHI is 1.2% undervalued, with a fair value of $85.63. However, tenant concentration and potential share dilution are identified as pressure points, while the company's P/E ratio is above the healthcare REIT average but below its fair ratio.
Restricted stock grant boosts National Health Investors (NHI) director holdings
National Health Investors (NHI) director James R. Jobe received a restricted stock grant of 1,268 common shares on March 3, 2026. This grant, which vests fully on March 3, 2027, provided at no cost, increases his direct holdings while contingent on his continued board service. Jobe also has additional holdings including 33,497 common shares jointly held with his spouse and 500 common shares in an IRA SEP.
How National Health Investors Inc. (NHI) Affects Rotational Strategy Timing
National Health Investors Inc. (NHI) is showing weak near and mid-term sentiment, although its long-term outlook remains positive. AI models have generated distinct trading strategies, including a long position, a momentum breakout, and a short-side risk hedging strategy. The analysis highlights a critical 20.1:1 risk-reward short setup, signaling potential downside.
National Health Investors (NHI) director receives 1,268-share restricted stock grant
National Health Investors (NHI) director Candice W. Todd received a grant of 1,268 restricted common shares on March 3, 2026. These shares will fully vest on March 3, 2027, provided she continues her service as a director, bringing her direct holdings to 2,563 shares. The transaction was reported via an SEC Form 4 filing, indicating the shares were a grant with a price per share of $0.0000.
NHI director Tracy Colden (NYSE: NHI) awarded 1,268 restricted shares
NHI director Tracy Colden was awarded 1,268 restricted shares of National Health Investors common stock on March 3, 2026, as per a Form 4 SEC filing. These shares will vest in full on March 3, 2027, contingent upon her continued service on the board, bringing her total direct holdings to 12,858 shares. The grant is a compensation award, not a market purchase, and no shares were sold.
National Health Investors, Inc. $NHI Shares Sold by Citigroup Inc.
Citigroup Inc. reduced its stake in National Health Investors (NYSE:NHI) by 26.9% in the third quarter of 2025, selling 19,465 shares and retaining 52,838 shares valued at approximately $4.20 million. The company announced a quarterly dividend of $0.92 per share, resulting in an annualized yield of about 4.3%. NHI's Q4 earnings missed consensus by $0.01, though revenue was up 6.8%, and the company maintains a "Moderate Buy" analyst consensus with an average price target of $85.57.
The Bull Case For National Health Investors (NHI) Could Change Following Board Shake-Up And Governance Shift
National Health Investors (NHI) recently appointed a senior housing veteran, Lilly H. Donohue, to its board and completed its board declassification. This move, alongside the CEO's reappointment to align with new election cycles, aims to strengthen operational expertise and governance as NHI expands its Senior Housing Operating Portfolio (SHOP). Investors should consider how Donohue's experience and improved governance might impact the company's focus on SHOP, addressing occupancy softness and tenant concentration risks.
Assessing National Health Investors (NHI) Valuation After Recent Share Price Weakness
National Health Investors (NHI) recently experienced a 4.1% one-day share price decline, despite exhibiting longer-term momentum. While a valuation model suggests NHI is 56.6% undervalued with a fair value of $85.63, the company's current P/E ratio of 28.7x is higher than the industry average, indicating mixed signals for investors. The article encourages investors to review underlying data and consider both the intrinsic value and market multiple perspectives.
Is NHI’s Latest Senior Housing Expansion Quietly Redefining Its Core Investment Story?
National Health Investors (NHI) has expanded its real estate portfolio by acquiring nine new properties across three states, coinciding with raised earnings estimates. This expansion, coupled with positive analyst revisions, suggests a potential redefinition of NHI's investment narrative, emphasizing its ability to convert demographic demand into stable cash flows within the senior housing sector. However, investors are cautioned to consider the ongoing risk of occupancy and margin pressures in its senior housing operating portfolio (SHOP) segment despite the promising growth.
Assessing National Health Investors (NHI) Valuation After Recent Share Price Weakness
National Health Investors (NHI) has seen recent share price weakness despite strong longer-term returns. Simply Wall St's valuation model suggests NHI is slightly undervalued with a fair value of $85.63, reflecting consistent revenue growth expectations. However, its P/E ratio is higher than the industry average, indicating mixed signals for investors based on market multiples versus intrinsic value.
National Health Investors Q4 Earnings Call Highlights
National Health Investors (NYSE: NHI) reported Q4 2025 results showing an 8.9% rise in normalized FFO per share, driven by its Seniors Housing Operating Portfolio (SHOP) whose NOI jumped 125% year-over-year. The company had an active investment year, completing $392.4 million in acquisitions and outlining a substantial pipeline for 2026. NHI lowered its target leverage, declared a $0.92 dividend, and provided 2026 guidance forecasting midpoint Nareit FFO growth of 6.9%.
National Health Investors, Inc. (NYSE:NHI) Q4 2025 Earnings Call Transcript
National Health Investors, Inc. (NHI) reported a strong Q4 2025, with normalized FFO per share growth of 8.9% and full-year growth of 10.6%, surpassing initial guidance. The company's SHOP platform was a key driver, seeing significant NOI growth and increased investment, particularly in senior housing. NHI also announced a shift in its leverage policy, a growing pipeline for future investments, and an active internal discussion regarding the NHC lease renewal.
Truist Financial Maintains National Health Investors Inc(NHI.US) With Buy Rating
Truist Financial analyst Michael Lewis has maintained a Buy rating on National Health Investors Inc (NHI.US). According to TipRanks data, Lewis has a 65.1% success rate and an average return of 9.5% over the past year. This information is provided for informational purposes and is not investment advice.
